Date published: 2025-10-15

1-800-457-3801

SCBT Portrait Logo
Seach Input

Quinolactacin A

0.0(0)
Write a reviewAsk a question

Application:
Quinolactacin A is a TNFα and AChE inhibitor for proteomics research
Molecular Weight:
270.33
Molecular Formula:
C16H18N2O2
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

Quinolactacin A is a chemical compound belonging to the class of quinolones, characterized by a core quinoline structure linked to a lactone group. This structure provides Quinolactacin A with distinctive chemical properties that make it an intriguing subject of study in various fields of chemistry and biochemistry. In research, Quinolactacin A has been primarily studied for its role in the modulation of bacterial quorum sensing mechanisms. Quorum sensing is a critical communication system that bacteria use to coordinate their behavior in response to population density. Quinolactacin A′s mechanism involves the disruption of this communication pathway, which is achieved through its interaction with the bacterial receptors that sense autoinducer molecules. This interaction prevents the bacteria from effectively communicating, thus affecting their collective behaviors like virulence factor production and biofilm formation. Furthermore, Quinolactacin A has been utilized in studies investigating its potential as a scaffold for synthetic modifications. Researchers aim to modify its quinoline and lactone moieties to explore how changes in these structures affect biological activity and stability.


Quinolactacin A References

  1. Quinolactacins A, B and C: novel quinolone compounds from Penicillium sp. EPF-6. I. Taxonomy, production, isolation and biological properties.  |  Kakinuma, N., et al. 2000. J Antibiot (Tokyo). 53: 1247-51. PMID: 11213284
  2. Quinolactacins A, B and C: novel quinolone compounds from Penicillium sp. EPF-6. II. Physico-chemical properties and structure elucidation.  |  Takahashi, S., et al. 2000. J Antibiot (Tokyo). 53: 1252-6. PMID: 11213285
  3. Quinolactacins A1 and A2, new acetylcholinesterase inhibitors from Penicillium citrinum.  |  Kim, WG., et al. 2001. J Antibiot (Tokyo). 54: 831-5. PMID: 11776439
  4. Biosynthesis of quinolactacin A, a TNF production inhibitor.  |  Sasaki, T., et al. 2006. J Antibiot (Tokyo). 59: 418-27. PMID: 17025018
  5. Engineered Biosynthesis of Fungal 4-Quinolone Natural Products.  |  Liu, M., et al. 2020. Org Lett. 22: 6637-6641. PMID: 32806159
  6. Heteroexpression of Aspergillus nidulans laeA in Marine-Derived Fungi Triggers Upregulation of Secondary Metabolite Biosynthetic Genes.  |  Khan, I., et al. 2020. Mar Drugs. 18: PMID: 33352941
  7. Co-occurrence and toxicological relevance of secondary metabolites in dairy cow feed from Thailand.  |  Awapak, D., et al. 2021. Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 38: 1013-1027. PMID: 33861173
  8. Total synthesis of quinolactacin-H from marine-derived Penicillium sp. ENP701 and biological activities.  |  Zhu, JX., et al. 2020. RSC Adv. 10: 24251-24254. PMID: 35516178
  9. Effect of different storage conditions on the stability and safety of almonds.  |  Rodrigues, P., et al. 2023. J Food Sci. 88: 848-859. PMID: 36633227
  10. An expedient synthesis of (+)-quinolactacin A2.  |  Park and Su-Jin, et al. 2004. Tetrahedron letters. 45.48: 8793-8795.

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

Quinolactacin A, 1 mg

sc-396540
1 mg
$235.00